ScaleReady’s Post

If you're looking to learn from the past and 𝗽𝗿𝗼𝗽𝗲𝗹 𝘆𝗼𝘂𝗿 𝗺𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘁𝗼 𝗰𝗹𝗶𝗻𝗶𝗰, look no further than the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁!   𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 𝗛𝗲𝗿𝗲 ➡️ https://ter.li/3pt48z   𝗨𝗻𝗶𝘁𝗶𝗻𝗴 𝟲𝟬+ 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗮𝗻𝗱 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗮 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.💡   𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 ➡️ https://ter.li/3pt48z   This is an incredible opportunity to unlock the full potential of your own macrophage therapeutics, with insights from 𝗖𝗮𝗿𝗶𝘀𝗺𝗮 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗘𝗹𝗽𝗶𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀, 𝗝𝗼𝗵𝗻 𝗛𝗼𝗽𝗸𝗶𝗻𝘀 𝗦𝗰𝗵𝗼𝗼𝗹 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲, 𝗔𝗟𝗫 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝗩𝗲𝗿𝘀𝗲𝗮𝘂 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, and many more!🔓   𝗝𝗼𝗶𝗻 𝘂𝘀 𝗶𝗻 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 ➡️ https://ter.li/l16k0n   #MacrophageDirectedTherapiesSummit

How to generate high-quality, monoclonal cell populations in cell line development (CLD)? 🌟 If you're a scientist facing challenges with precise single-cell seeding, boosting cell line purity, scalability, or isolating rare cells, read this blog by Dr. Katrin Raute, PhD for success strategies that also help with regulatory compliance. 💡 Inside the Blog: ✔️ Importance of single-cell seeding ✔️ Methods to ensure traceability and regulatory compliance ✔️ Isolation of rare cells in oncology and microbiome research ✔️ Verifying cell viability and purity … and more. Access the full article now. 📖👇 https://lnkd.in/eF2iA9a4 #CellLineDevelopment #SingleCellSeeding #HealthCareInnovation #Biotech #Blog

Integrating The 3Rs Collaborative (3RsC) is in line with our values for changing the dogmas of animal 🐀 usage during the drug development process 💊 . We are convinced that PredictCan Biotechnologies cell educating technology can strongly contribute to reduce animal usage. Many thanks to Clive Roper BSc PhD CBiol CSci ERT FRSB and Megan LaFollette for their help to joining the 3Rs community. #Predictcan #3R #animal #precisionmedicine

Attention all Macrophage Experts! 📢 If you're looking to learn from the past and 𝗽𝗿𝗼𝗽𝗲𝗹 𝘆𝗼𝘂𝗿 𝗺𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘁𝗼 𝗰𝗹𝗶𝗻𝗶𝗰, look no further than the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁! 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 𝗛𝗲𝗿𝗲 ➡️ https://bit.ly/455dOQ7 𝗨𝗻𝗶𝘁𝗶𝗻𝗴 𝟲𝟬+ 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗮𝗻𝗱 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗮 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.💡 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 ➡️ https://bit.ly/455dOQ7 This is an incredible opportunity to unlock the full potential of your own macrophage therapeutics, with insights from 𝗖𝗮𝗿𝗶𝘀𝗺𝗮 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗘𝗹𝗽𝗶𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀, 𝗝𝗼𝗵𝗻 𝗛𝗼𝗽𝗸𝗶𝗻𝘀 𝗦𝗰𝗵𝗼𝗼𝗹 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲, 𝗔𝗟𝗫 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝗩𝗲𝗿𝘀𝗲𝗮𝘂 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, and many more!🔓 Book your seat at https://bit.ly/450Afpr before Friday to 𝘀𝗮𝘃𝗲 𝘂𝗽 𝘁𝗼 $𝟵𝟬𝟬, plus an 𝗮𝗱𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝟮𝟬% 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁 when you bring 5 or more colleagues, which will facilitate valuable collaborative learning within your team. #MacrophageDirectedTherapiesSummit

Attention all Macrophage Experts! 📢 If you're looking to learn from the past and 𝗽𝗿𝗼𝗽𝗲𝗹 𝘆𝗼𝘂𝗿 𝗺𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘁𝗼 𝗰𝗹𝗶𝗻𝗶𝗰, look no further than the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁! 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 𝗛𝗲𝗿𝗲 ➡️ https://bit.ly/455dOQ7 𝗨𝗻𝗶𝘁𝗶𝗻𝗴 𝟲𝟬+ 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗮𝗻𝗱 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗮 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 across R&D, discovery, biology, translational science, and clinical development, this is poised to be a must-attend event, deep-diving into the evolving macrophage-therapeutics landscape, exploring other indications, and tackling the most pressing industry challenges.💡 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗣𝗿𝗼𝗴𝗿𝗮𝗺 ➡️ https://bit.ly/455dOQ7 This is an incredible opportunity to unlock the full potential of your own macrophage therapeutics, with insights from 𝗖𝗮𝗿𝗶𝘀𝗺𝗮 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗘𝗹𝗽𝗶𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀, 𝗝𝗼𝗵𝗻 𝗛𝗼𝗽𝗸𝗶𝗻𝘀 𝗦𝗰𝗵𝗼𝗼𝗹 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲, 𝗔𝗟𝗫 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝗩𝗲𝗿𝘀𝗲𝗮𝘂 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, and many more!🔓 Book your seat at https://bit.ly/450Afpr before Friday to 𝘀𝗮𝘃𝗲 𝘂𝗽 𝘁𝗼 $𝟳𝟬𝟬, plus an 𝗮𝗱𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝟮𝟬% 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁 when you bring 5 or more colleagues, which will facilitate valuable collaborative learning within your team. #MacrophageDirectedTherapiesSummit

🚀 Watch this on-demand expert panel dialog and download the executive summary! 🌟 Learn from industry leaders about the significance of circRNA technology in medicine, key analytical technologies, and the challenges of developing circRNA therapeutics. 📅 Event Highlights: • Expert presentations on therapeutic applications, structural identification, and analytical methods. • In-depth discussion with experts. 👥 Featuring: • Francis Poulin (Sail Biomedicines) • Nikoloas Mellios (Circular Genomics) • Andy Coffey (Agilent) Don’t miss this chance to gain valuable insights! 💡 https://bit.ly/4f9Cbjt #circRNA #Biotechnology #ExpertDiscussion

Achieve homogeneous cell spreading with the NEW VitroPrime™ Spread-Attach Plate. This unique-surface treated plate ensure even cell attachment through the surface, solving the issue of uneven hydrogel surfaces which can lead to variations in cell distribution on different z-level. This inconsistency can result in challenges in data generation and imaging. Learn more about this new VitroPrime™ Spread-Attach Plates: https://lnkd.in/gGxMXTeJ Get to know our xeno-free VitroGel® hydrogels, where you can achieve more reproducible and consistent data for 3D cell culture applications. VitroGel® hydrogels allow you to translate your research to clinical applications and is more ethical than animal-based ECM: https://lnkd.in/eVVKamk #3DCellCulture #biotech #biotechnology #cellculture #organoid #stemcells #matrigel #cancerresearch #celltherapy #vitrogel #invivo #oncology #drugdiscovery #tissueengineering #vitroprime

We are thrilled to celebrate the recent announcement of a nearly $200-million partnership between Aspect Biosystems and the Government of British Columbia and Government of Canada! As early investors in Aspect Biosystems through our I² Program, Genome BC is proud to witness this incredible milestone. This partnership will create over 200 high-quality jobs and advance the development of cutting-edge bioprinted tissue therapeutics, revolutionizing treatment options for people in B.C. and around the world.                                                                   Aspect Biosystems' pioneering work in bioprinted tissue therapeutics represents a major step forward in regenerative medicine. This investment will help establish clinical biomanufacturing capabilities, advance technology, and expand their therapeutic pipeline for diseases like diabetes, obesity and liver disease. We are excited to continue supporting Aspect Biosystems and the thriving life sciences sector in B.C. Learn more about this partnership and the future of bioprinted tissue therapeutics. https://lnkd.in/gq2sSBCH #AspectBiosystems #RegenerativeMedicine #Biomanufacturing #JobsBC

At Cirrus Therapeutics, every day marks a new milestone in our quest to conquer age-related macular degeneration (AMD). The team's dedication to discovery comes to life in our state-of-the-art labs where collaboration meets innovation,  forging a path to groundbreaking treatments. "Working here isn’t just about the science; it’s about creating real-world solutions that will one day improve the lives of millions globally," shares Dr. Sumeet Sarin, Project Lead at Cirrus. "The energy here is electric—we're not just studying the disease, we're actively fighting it with every experiment, every breakthrough." Cirrus, born from the pioneering spirits of Cofounders Dr. Ying Kai Chan and Dr. Andrew Dick, is championing a novel approach to treating AMD by enhancing the IRAK-M protein in retinal cells, promising a significant advancement in available therapies. ➡️ Follow us on our journey as we bring visionary science from the lab to the lives of patients around the world. #vision #AMD #DryAMD #WetAMD #optometry #ophthalmology #healthcare #innovation #science #research #termeerfellow #biotech #STEM